AcelRx Pharmaceuticals Stock Analysis
Technical stock analysis for 18 January 2019
AcelRx Pharmaceuticals gained 1.21% in the last trading day, rising from $2.48 to $2.51 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has fallen in 5 of the last 10 days and is down by -8.39% for this period. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 0.07 million more shares were traded than the day before. In total, 2.13 million shares bought and sold for approximately $5.35 million.
Close price at the end of the last trading day (Friday, 18th Jan 2019) of the ACRX stock was $2.51. This is 1.21% more than the trading day before Thursday, 17th Jan 2019.
During day the stock fluctuated 9.05% from a day low at $2.43 to a day high of $2.65.
30 day high of the ACRX stock price was $2.92 and low was $1.99.
90 day high was $5.05 and low was $1.99.
52 week high for the AcelRx Pharmaceuticals - $5.05 and low - $1.65.
AcelRx Pharmaceuticals lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -36.72% during the next 3 months and, with 90% probability hold a price between $0.98 and $2.05 at the end of this period.
A buy signal was issued from a pivot bottom point on Tuesday January 15, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. AcelRx Pharmaceuticals holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $2.72. On a fall, the stock will find some support from the short-term average at $2.49. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal.
Relative Strength Index (RSI)
RSI14 is 57 and the stock is currently not being overbought or oversold
Support & Resistance
AcelRx Pharmaceuticals finds support from accumulated volume at $2.48.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.22 between high and low, or 9.05%. For the last week, the stock has had a daily average volatility of 9.22%.
Our recommended stoploss: $2.39 (-4.88%) (This stock has high daily movements and this gives high risk. There is a buy signal from pivot bottom found 3 days ago.)
Very Low Low Medium High Very High
AcelRx Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development.
|ACRX $2.51 $0.03(1.21%)|
ACRX is up $0.03 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ACRX based on the 1-3 month system that more than doubles the S&P 500.
Click here – the ACRX analysis is free »